# Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection

> **NCT01915212** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 69 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** HSV529
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01915212
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-26
- **Primary completion:** 2017-03-06
- **Final completion:** 2017-03-06
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01915212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01915212, "Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT01915212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*